| Literature DB >> 16169218 |
Xin-Jie Chu1, David Bartkovitz, Waleed Danho, Joseph Swistok, Adrian Wai-Hing Cheung, Grazyna Kurylko, Karen Rowan, Mitch Yeon, Lucia Franco, Lida Qi, Li Chen, Keith Yagaloff.
Abstract
Linear pentapeptides (Penta-cis-Apc-DPhe-Arg-Trp-Gly-NH2) containing 1-amino-4-phenylcyclohexane-1-carboxylic acid (cis-Apc) and substituted Apc are potent hMC4R agonists and they are inactive or weakly active in hMC1R, hMC3R, and hMC5R agonist assays. This study, together with our earlier report on 5-BrAtc, demonstrated the importance of replacing His6 with phenyl-containing rigid templates in achieving good hMC4R agonist potency and selectivity against hMC1R in linear pentapeptides.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16169218 DOI: 10.1016/j.bmcl.2005.08.012
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823